인쇄하기
취소

KFDA to promote biosimilar industry

Published: 2011-02-15 07:00:00
Updated: 2011-02-15 07:00:00
The Korea Food and Drug Administration has recently pledged to promote the biosimilar industry.

To this end, the drug agency will organize its task force team to provide proper consulting to local firms, with a plan to establish the guideline for evaluation of the safety and efficacy of biosimilar drugs.

Biosimilars, or imitation biopharmaceuticals, are officially approved subsequent vers...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.